Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: Disease activity and the use of cytotoxic drugs

Lupus

Volumn 11, Issue 7, 2002, Pages 443-450

  Vasoo, S ^a   Thumboo, J ^a   Fong, K Y ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Immunosuppressive agents; Lupus erythematosus systemic; Purpura; Thrombotic thrombocytopenic

Indexed keywords

CYTOTOXIC AGENT; IMMUNOSUPPRESSIVE AGENT; CYTOTOXIN;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; HEMATOLOGIC DISEASE; HUMAN; MALE; MORTALITY; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; PURPURA; REMISSION; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; HOSPITALIZATION; MIDDLE AGED; REVIEW;

ADULT; CASE REPORT; CYTOTOXINS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGE; PURPURA, THROMBOTIC THROMBOCYTOPENIC; SEVERITY OF ILLNESS INDEX; HUMANS; MIDDLE AGED;

EID: 0036024141     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203302lu224oa     Document Type: Article

References (35)

1. Thrombotic thrombocytopenic purpura and autoimmunity: A tale of shadows and suspects
2. Thrombotic thrombocytopenic purpura
3. Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus
4. Management of thrombotic thrombocytopenic purpura
5. Thrombotic syndromes and autoimmune disease
6. Vincristine sulphate for the treatment of thrombotic thrombocytopenic purpura refractory to plasma-exchange
7. A successful combination of plasma exchange and intravenous cyclophosphamide in a patient with a refractory thrombotic thrombocytopenic purpura
8. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus
9. Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study
10. Thrombotic thrombocytopenic purpura
11. The pathophysiology and management of thrombotic thrombocytopenic purpura
12. Thrombotic thrombocytopenic purpura: Early and late responders
13. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): Treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases
14. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus and antiphospholipid antibodies. Effective treatment with plasma exchange and immunosuppression
15. Thrombotic thrombocytopenic purpura syndrome in systemic lupus erythematosus: Treatment with plasma infusion
16. Thrombotic microangiopathic hemolytic anemia in systemic lupus erythematosus
17. Systemic lupus erythematosus complicated by thrombotic microangiopathy
18. Concurrent development of thrombotic thrombocytopenic purpura and systemic lupus erythematosus in a male patient
19. Fulminant thrombotic thrombocytopenic purpura in systemic lupus erythematosus
20. Thrombotic thrombocytopenic purpura in a patient with systemic lupus erythematosus
21. TTP-like syndrome in a 44-year-old woman with SLE and nephritis
22. Use of cyclophosphamide in the treatment of thrombotic thrombocytopenic purpura complicating systemic lupus erythematosus: Report of two cases
23. Fulminant thrombotic thrombocytopenic purpura in two patients with systemic lupus erythematosus and phospholipid antibodies
24. Thrombotic thrombocytopenic purpura and systemic lupus erythematosus
25. Thrombotic thrombocytopenic purpura in a girl with systemic lupus erythematosus
26. Systemic lupus erythematosus presenting as thrombotic thrombocytopenic purpura
27. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus
28. Systemic lupus erythematosus and thrombotic trombocytopenic purpura. Report of three cases and review of the literature
29. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
30. Thrombotic thrombocytopenic purpura: A paradigm shift?
31. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome
32. Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: A study of 111 cases
33. Suppression of human B lymphocyte function by cyclophosphamide
34. Vincristine as salvage treatment for refractory thrombotic thrombocytopenic purpura
35. Severe infections in plasmapheresis-treated systemic lupus erythematosus